Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000815725 | SCV000956193 | uncertain significance | 3-hydroxy-3-methylglutaryl-CoA synthase deficiency | 2022-03-10 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 658831). This variant has not been reported in the literature in individuals affected with HMGCS2-related conditions. This variant is present in population databases (rs72695184, gnomAD 0.03%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 3 of the HMGCS2 protein (p.Arg3His). |
Breakthrough Genomics, |
RCV004691311 | SCV005186860 | uncertain significance | not provided | criteria provided, single submitter | not provided |